Nelfinavir inhibition of Kaposi’s sarcoma-associated herpesvirus protein expression and capsid assembly

Abstract Background Antiviral therapies that target herpesviruses are clinically important. Nelfinavir is a protease inhibitor that targets the human immunodeficiency virus (HIV) aspartyl protease. Previous studies demonstrated that this drug could also inhibit Kaposi’s sarcoma-associated herpesviru...

Cijeli opis

Bibliografski detalji

Glavni autori:	Maggie Li, Barbara J. Smith, Jaeyeun Lee, Jennifer Petr, Nicole M. Anders, Robyn Wiseman, Michelle A. Rudek, Richard F. Ambinder, Prashant J. Desai
Format:	Artigo
Jezik:	Inglês
Izdano:	BMC 2024-03-01
Serija:	Infectious Agents and Cancer
Teme:	Kaposi’s sarcoma-associated herpesvirus Nelfinavir Virus inhibition Integrated stress response Virus assembly
Online pristup:	https://doi.org/10.1186/s13027-024-00566-7
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!